Fact Sheet | Pricing

Part B International Drug Pricing Model for Medicare Part B Drugs

Fact Sheet | Pricing

Part B International Drug Pricing Model for Medicare Part B Drugs

The International Pricing Index (IPI) Model would initially focus on Part B single source drugs, biologicals, and biosimilars that encompass a high percentage of Part B drug utilization and spending. The CMS Innovation Center would test this model under section 1115A of the Social Security Act (the Act), which authorizes testing models expected to reduce program expenditures, while preserving or enhancing the quality of care furnished to beneficiaries. The model under consideration would include physicians, hospitals, and potentially other providers and suppliers in selected geographic areas.

Download the fact sheet

Advertisements

Related Articles | Pricing

News | Coronavirus

HFMA recommended coronavirus resources

The coronavirus is affecting the healthcare industry in unprecedented ways, and HFMA wants to help you stay up to date on the latest news about the outbreak. Come back to this page regularly for coronavirus resources, selected specifically for healthcare finance professionals, including Medicare information on regulations and guidelines, COVID-19 test pricing, COVID-19 coding, telehealth billing FAQs and more.

Column | Consumerism

Price transparency as a guiding principle: directionally correct

HFMA President and CEO Joe Fifer offers a perspective on HFMA’s approach to price transparency vis-à-vis the upcoming CMS regulations on payment rate transparency.

How To | Pricing

How to develop a winning pricing strategy in the post-COVID-19 consumer market

Providers and health plans should prepare for federally imposed price transparency mandates imposed by developing comprehensive pricing strategies tailored to their specific market positions, financials and operational objectives.

Comment Letter | Payment, Reimbursement, and Managed Care

HFMA Comments on Measures to Ensure Safety Net Hospital Operational Sustainability

HFMA presents its comment letter to Congressional leaders on measures to ensure the operational sustainability of safety net hospitals.